Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fixed-dose Ledipasvir/Sofosbuvir with or without Vedroprevir (with or without ribavirin) in treatment-experienced chronic genotype 1 HC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis with Genotype 1
• Cirrhosis
• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)
• Vedroprevir (vedroprevir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2016-03-04